Table 2.
Modified Peptidea | Modification Siteb | Typec |
---|---|---|
ALVLIAFAQYLQQC#PFEDHVK | Cys34 | MA |
SLH@TLFGDK | His67 | MA |
NECFLQH@K | His105 | MA |
VH@TECCHGDLLECADDR | His242 | MA |
VHTECCH@GDLLECADDR | His247 | MA |
SH@CIAEVENDEM*PADLPSLAADFVESK | His288 | MA |
SH@CIAEVENDEMPADLPSLAADFVESK | His288 | MA |
CCAAADPH@ECYAK | His367 | MA |
EFNAETFTFH@ADICTLSEK | His510 | MA |
LVNEVTEFAKˆTCVAD | Lys51 | MA |
YKˆAAFTECCQAADK | Lys162 | MA |
LKˆCASLQK | Lys199 | MA |
AFKˆAWAVAR | Lys212 | MA |
AEFAEVSKˆLVTDLTK | Lys233 | MA |
ADLAKˆYICENQDSISSK | Lys262 | MA |
LAKˆTYETTLEK | Lys351 | MA |
VFDEFKˆPLVEEPQNLIK | Lys378 | MA |
KˆVPQVSTPTLVEVSR | Lys414 | MA |
K∼VPQVSTPTLVEVSR | Lys414 | SB |
KˆQTALVELVK | Lys525 | MA |
K∼QTALVELVK | Lys525 | SB |
Unmodified versions of the listed modified peptides and peptides resulting from cleavage with trypsin of unmodified versions of the listed modified peptides were also targeted; C# indicates HNE Michael addition at Cys followed by reduction; H@ indicates HNE Michael addition at His followed by reduction; Kˆ indicates HNE Michael addition at Lys followed by reduction; K∼ indicates Schiff base formation with HNE at Lys followed by reduction; M* indicates oxidation at Met
Secreted protein numbering; add 24 for nascent protein
MA indicates Michael addition; SB indicates Schiff base formation